| abstract |
Compound of formula ** (See formula) ** that can be in the form of a base or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for use in the treatment of prostate cancer, in cancer patients castration-resistant metastatic prostate patients who have previously been treated with a docetaxel-based regimen and have prostate cancer that has progressed during or after such treatment. |